Abstract
Graphical AbstractThis review summarizes and critically analyzes the latest therapeutic research on nanoparticle-mediated delivery systems targeting breast cancer drug resistance, metastasis, and immune escape in breast cancer and discusses the challenges and opportunities of nanoparticle-based therapy.
Subject
Pharmacology (medical),Pharmacology
Reference129 articles.
1. Nanoparticulate alternatives for drug delivery;Adair;ACS Nano,2010
2. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
3. Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study;Adams;Ann. Oncol.,2019
4. Metastatic breast cancer subtypes and central nervous system metastases;Aversa;Breast,2014
5. Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: Reciprocal tumor-microenvironment interactions;Ben-Baruch;Breast Cancer Res.,2003
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献